Literature DB >> 10386941

An efficient stereoselective synthesis of [3S(1S,9S)]-3-[[[9-(benzoylamino) octahydro-6,10-dioxo-6H-pyridazino-(1,2-a)(1,2)-diazepin-1-yl]-carbonyl ]amino]-4-oxobutanoic acid, an interleukin converting enzyme (ICE) inhibitor.

M H Chen1, O P Goel, J W Hyun, J Magano, J R Rubin.   

Abstract

The title compound 1 is a potent interleukin-1beta-converting enzyme (ICE) inhibitor. Recently, an efficient chiral synthesis of compound 1 has been accomplished in our labs. The overall yield of this 18-step stereoselective synthesis was 9.8%.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386941     DOI: 10.1016/s0960-894x(99)00236-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Solid-phase synthesis of tetrahydropyridazinedione-constrained peptides.

Authors:  Chang Won Kang; Sujeewa Ranatunga; Matthew P Sarnowski; Juan R Del Valle
Journal:  Org Lett       Date:  2014-10-08       Impact factor: 6.005

Review 2.  Caspases as therapeutic targets.

Authors:  B Howley; H O Fearnhead
Journal:  J Cell Mol Med       Date:  2008-02-24       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.